Literature DB >> 11292488

Expression of single-chain Fv-Fc fusions in Pichia pastoris.

D B Powers1, P Amersdorfer, M Poul, U B Nielsen, M R Shalaby, G P Adams, L M Weiner, J D Marks.   

Abstract

Phage display technology makes possible the direct isolation of monovalent single-chain Fv antibody fragments. For many applications, however, it is useful to restore Fc mediated antibody functions such as avidity, effector functions and a prolonged serum half-life. We have constructed vectors for the convenient, rapid expression of a single-chain antibody Fv domain (scFv) fused to the Fc portion of human IgG1 in the methylotrophic yeast Pichia pastoris. The scFv-Fc fusion protein is secreted and recovered from the culture medium as a disulfide-linked, glycosylated homodimer. The increased size of the dimer (approximately 106 kDa vs. approximately 25 kDa for a scFv) results in a prolonged serum half-life in vivo, with t(1/2) of the beta phase of clearance increasing from 3.5 h for a typical scFv to 93 h for a scFv-Fc fusion in mice. The scFv-Fc fusion is capable of mediating antibody-dependent cellular cytotoxicity against tumor target cells using human peripheral blood mononuclear cells as effectors. Finally, the Fc domain is a convenient, robust affinity handle for purification and immunochemical applications, eliminating the need for proteolytically sensitive epitope and/or affinity tags on the scFv.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292488     DOI: 10.1016/s0022-1759(00)00290-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  30 in total

1.  Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.

Authors:  B P Mullaney; M G Pallavicini; J D Marks
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Screening phage display libraries for organ-specific vascular immunotargeting in vivo.

Authors:  Philippe Valadon; Jeff D Garnett; Jacqueline E Testa; Marc Bauerle; Phil Oh; Jan E Schnitzer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

3.  Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds.

Authors:  Bart Van Droogenbroeck; Jingyuan Cao; Johannes Stadlmann; Friedrich Altmann; Sarah Colanesi; Stefan Hillmer; David G Robinson; Els Van Lerberge; Nancy Terryn; Marc Van Montagu; Mifang Liang; Ann Depicker; Geert De Jaeger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

4.  Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources.

Authors:  Benjamin J Tillotson; Iñigo F de Larrinoa; Colin A Skinner; Derek M Klavas; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2012-10-28       Impact factor: 1.650

5.  Expression of Bacillus licheniformis α-amylase in Pichia pastoris without antibiotics-resistant gene and effects of glycosylation on the enzymic thermostability.

Authors:  Xinlin Hu; Xin Yuan; Nisha He; Tony Z Zhuang; Pan Wu; Guimin Zhang
Journal:  3 Biotech       Date:  2019-10-29       Impact factor: 2.406

Review 6.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

7.  Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.

Authors:  Ian G Goodfellow; David J Evans; Anna M Blom; Dave Kerrigan; J Scott Miners; B Paul Morgan; O Brad Spiller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Identification of tumor associated single-chain Fv by panning and screening antibody phage library using tumor cells.

Authors:  Yong-Zhan Nie; Feng-Tian He; Zhi-Kui Li; Kai-Chun Wu; Yun-Xin Cao; Bao-Jun Chen; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  A multi-Fc-species system for recombinant antibody production.

Authors:  Sandrine Moutel; Ahmed El Marjou; Ole Vielemeyer; Clément Nizak; Philippe Benaroch; Stefan Dübel; Franck Perez
Journal:  BMC Biotechnol       Date:  2009-02-26       Impact factor: 2.563

10.  A human, compact, fully functional anti-ErbB2 antibody as a novel antitumour agent.

Authors:  C De Lorenzo; A Tedesco; G Terrazzano; R Cozzolino; P Laccetti; R Piccoli; G D'Alessio
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.